San Diego, CA –– BioMed Realty Trust, Inc. (NYSE: BMR) today announced that Illumina, Inc. (NASDAQ: ILMN), a world leader in genomics focused on improving human health by unlocking the power of the genome, has signed a 20-year lease for a 155,000 square foot new and innovative scientific research building in Cambridge, England. The project […]
Oxford Gene Technology (OGT), The Molecular Genetics Company, is today launching a new range of arrays at the European Society of Human Genetics (ESHG) Conference in Glasgow, UK, that are dedicated to elucidating the underlying causes of developmental delay. OGT’s unique Cytosure™ Constitutional v3 arrays have been developed following its recent licence agreement with the […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced updates to its SurePrint gene expression microarrays for messenger RNA profiling applications for human, mouse and rat models. The updates improve coding and noncoding content, which will provide up-to-date tools for researchers to investigate expression patterns on a highly accessible platform. Agilent developed the […]
SANTA CLARA, Calif. — Affymetrix (NASDAQ: AFFX) today announced that Riccardo Pigliucci has been appointed to the company’s board of directors effective May 13, 2015. Mr. Pigliucci will serve as a member of the Compensation Committee. Mr. Pigliucci has served as the Managing Partner of Aldwych Associates, LLP, a management and technology consulting partnership since […]
SANTA CLARA, Calif. — Affymetrix, Inc., (NASDAQ:AFFX) announced today that it has acquired substantially all the assets of Hercules, CA-based Eureka Genomics® Corporation for $15 million in an all cash transaction. Eureka Genomics is a developer of cost-effective, low- to mid-plex, high throughput genotyping assays that use common next-generation sequencing (NGS) platforms for signal readout. […]
SUNNYVALE, CA — The ongoing Cooperative Research and Development Agreement (CRADA) between Arrayit Corporation (ARYC) and the United States Department of Agriculture (USDA), “Rapid and Cost Effective Detection Technologies for Noroviruses and other Foodborne Pathogens,” entitles Arrayit to an exclusive license to commercialize the technology. Much of the food consumed in the United States, including […]
LEXINGTON, Mass. –N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced that it has signed a business partner agreement with Affymetrix, a leading provider of DNA microarrays. Under this agreement, N-of-One will provide copy number variation (CNV) analysis interpretation for Affymetrix OncoScan assay customers. Financial terms of the agreement are […]
LEXINGTON, Mass. -– N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced that it has signed a business partner agreement with Affymetrix, a leading provider of DNA microarrays. Under this agreement, N-of-One will provide copy number variation (CNV) analysis interpretation for Affymetrix OncoScan assay customers. Financial terms of the agreement […]
SANTA CLARA, Calif., and BOSTON — Agilent Technologies Inc. (NYSE: A) and Cartagenia today announced that they have signed a definitive agreement under which Agilent will acquire Cartagenia, a leading provider of software and services for clinical genetics and molecular pathology labs. Cartagenia, which has offices in Leuven, Belgium, and Boston, Massachusetts, provides software solutions […]
Santa Clara, CA -– Affymetrix (NASDAQ: AFFX) will highlight its new Concurrent Molecular Analysis Profiling (CoMAP™) capability at the 2015 annual meeting of the American Association for Cancer Research. The program enables cancer researchers to gain rapid insight into the functional impact of DNA copy-number alterations by combining whole-genome copy-number data with gene expression profiles […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
